Carrier Testing in Hemophilia B With an Immunoassay That Distinguishes a Prevalent Factor

نویسندگان

  • Kenneth J. Smith
  • Arthur A. Thompson
  • Brad A. McMullen
  • Dan Frazier
  • Shu Wha Lin
  • Darrell Stafford
  • Walter Kisiel
  • Stephen N. Thibodeau
  • Shi-Han Chen
  • Leslie F. Smith
چکیده

lmmunoassays with a monoclonal antibody (A-i ) detect a prevalent dimorphism in plasma coagulation factor IX. The antibody was shown to react with a dimorphic segment of the normal factor IX sequence as follows. First. A-i bound to isolated activation peptide (residues 146 through 180) prepared from activated factor IX from a normal plasma pool. Second, binding of recombinant factor lXs with A-i or factor IX from normal individuals was strong only when they had Threonine (Thr) at position 148; factor lXs with the Alanine (Ala) allele at that position were far less reactive. Third. immunoblot reactivity of Escherichia coIl fusion proteins containing known segments of the factor IX sequence restricted the epitope to residues i47 through i 53. In i 20 hemophilia B pedigrees. the Ala immunoassay allele frequency was 0.i 9 and did not differ from the Ala frequency in normal males. In 22 of 49 families. immunoas-

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Carrier testing in hemophilia B with an immunoassay that distinguishes a prevalent factor IX dimorphism.

Immunoassays with a monoclonal antibody (A-1) detect a prevalent dimorphism in plasma coagulation factor IX. The antibody was shown to react with a dimorphic segment of the normal factor IX sequence as follows. First, A-1 bound to isolated activation peptide (residues 146 through 180) prepared from activated factor IX from a normal plasma pool. Second, binding of recombinant factor IXs with A-1...

متن کامل

Molecular Characterization of the Factor IX Gene in 28 Iranian Hemophilia B Patients

Background: Heterogeneous mutations in the human coagulation factor IX gene lead to an X-linked recessive bleeding disorder known as hemophilia B. The disease is distributed worldwide with no ethnic or geographical priority. Materials and Methods: The aim of this study was to characterize the factor IX gene mutations in 28 unrelated Iranian hemophilia B patients. Polymerase chain reaction (PCR)...

متن کامل

The Frequencies of three Factor IX-Linked Restriction Fragment Length Polymorphisms in Iranian Patients with Hemophilia B

Background: Hemophilia B is an X-linked recessive coagulation disorder caused by factor IX deficiency.  Analysis of factor IX gene polymorphisms is considered the best approach for prenatal diagnosis and carrier detection of hemophilia B where the identification of gene mutation is not easily possible. Objective: To study the frequency of three factor IX-linked restriction fragment length polym...

متن کامل

بررسی تنوع ژنتیکی مارکر rs438601در جمعیت اصفهان: یک مارکر آگاهی‌دهنده در تشخیص‌های مولکولی هموفیلی B

Introduction: Hemophilia B is an X-linked recessive genetic disease caused by mutations in the coagulation Factor IX gene. Mutations in the Factor IX gene result in dysfunction or deficiency of coagulation factor of IX. Direct mutation analysis involves the ideal method for molecular diagnosis of the disease. However, due to the high number of identified mutations in the gen, the lack of a comm...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2005